Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGSTU:8IM1 +1.82%36 Days Payable is 0.00 as of . 20. GuruFocus rates STU:8IM1 with a GF Score™ of 36/100. Among 795 Medical Devices & Instruments companies, Implantica AG ranks worse than 125786.04% on this metric.
The historical rank and industry rank for Implantica AG's Days Payable or its related term are showing as below:
STU:8IM1's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.87 * Ranked among companies with meaningful Days Payable only.
Implantica AG's Days Payable
stayed the same
from . 20 (0.00) to . 20 (0.00).
The historical data trend for Implantica AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Days Payable Chart
Implantica AG Annual Data
Trend
Days Payable
Implantica AG Semi-Annual Data
Days Payable
STU:8IM1 vs : Days Payable Comparison
For the Medical Devices subindustry, Implantica AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Implantica AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Implantica AG's Days Payable for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (STU:8IM1) has a Days Payable of 0.00 as of . 20. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 795 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Days Payable too high?
Implantica AG's current Days Payable is 0.00. Based on the distribution chart, Implantica AG ranks #999999 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Days Payable compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 795 companies for Days Payable. This places Implantica AG in the lower half of its industry. The industry median Days Payable is 67.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (STU:8IM1) has a current Days Payable of 0.00. The current Days Payable is 0.00. Implantica AG's overall GF Score™ is 36/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Implantica AG (STU:8IM1), the current Days Payable is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
36GF Score
Get the complete analysis for STU:8IM1
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8IM1 has been successfully added to your 
